{"id":30631,"date":"2016-09-29T20:18:01","date_gmt":"2016-09-30T03:18:01","guid":{"rendered":"http:\/\/lifeboat.com\/blog\/2016\/09\/readcoor-will-commercialize-the-wyss-institutes-fisseq-fluorescent-in-situ-rna-sequencing-technology"},"modified":"2017-06-04T14:12:31","modified_gmt":"2017-06-04T21:12:31","slug":"readcoor-will-commercialize-the-wyss-institutes-fisseq-fluorescent-in-situ-rna-sequencing-technology","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2016\/09\/readcoor-will-commercialize-the-wyss-institutes-fisseq-fluorescent-in-situ-rna-sequencing-technology","title":{"rendered":"ReadCoor will commercialize the Wyss Institute\u2019s (FISSEQ) fluorescent in situ RNA sequencing technology"},"content":{"rendered":"<p><a class=\"blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/readcoor-will-commercialize-the-wyss-institutes-fisseq-fluorescent-in-situ-rna-sequencing-technology.jpg\"><\/a><\/p>\n<p>Boston-based startup completes $23 million Series A financing to leverage novel imaging platform of gene locations towards gaining diagnostic insights and delivering therapeutics for cancer, immuno-oncology, infectious diseases, neurological and neuromuscular diseases, brain function and cognitive disorders<\/p>\n<p>BOSTON\u2014(<a rel=\"nofollow\" itemprop=\"url\" href=\"http:\/\/www.businesswire.com\/\">BUSINESS WIRE<\/a>)\u2014ReadCoor, Inc., today announced completion of an oversubscribed $23 million Series A financing round and its concurrent launch from Harvard University\u2019s Wyss Institute for Biologically Inspired Engineering. ReadCoor will commercialize the Wyss Institute\u2019s FISSEQ (fluorescent in situ sequencing) technology.<\/p>\n<blockquote><\/blockquote>\n<p><!-- Link: <a href=\"http:\/\/www.rna-seqblog.com\/readcoor-will-commercialize-the-wyss-institutes-fisseq-fluorescent-in-situ-rna-sequencing-technology\/\">http:\/\/www.rna-seqblog.com\/readcoor-will-commercialize-the-w...echnology\/<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston-based startup completes $23 million Series A financing to leverage novel imaging platform of gene locations towards gaining diagnostic insights and delivering therapeutics for cancer, immuno-oncology, infectious diseases, neurological and neuromuscular diseases, brain function and cognitive disorders BOSTON\u2014(BUSINESS WIRE)\u2014ReadCoor, Inc., today announced completion of an oversubscribed $23 million Series A financing round and its concurrent [\u2026]<\/p>\n","protected":false},"author":395,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,43,38,47],"tags":[],"class_list":["post-30631","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-business","category-engineering","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/30631","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/395"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=30631"}],"version-history":[{"count":3,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/30631\/revisions"}],"predecessor-version":[{"id":66121,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/30631\/revisions\/66121"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=30631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=30631"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=30631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}